US8342236044 - Common Stock
SOLIGENIX INC
NASDAQ:SNGX (7/26/2024, 7:00:02 PM)
After market: 4.65 +0.12 (+2.65%)4.53
+0.08 (+1.8%)
Soligenix Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Princeton, New Jersey and currently employs 13 full-time employees. Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics segment is developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). Development programs in this segment also include expansion of synthetic hypericin (SGX302) into psoriasis and dusquetide (SGX942 and SGX945) for the treatment of inflammatory diseases. Its Public Health Solutions segment includes development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease and its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax, its vaccine candidate for the prevention of COVID-19.
SOLIGENIX INC
Suite C-10, 29 Emmons Drive
Princeton NEW JERSEY 08540
P: 16095388200
CEO: Christopher J. Schaber
Employees: 13
Website: https://www.soligenix.com/
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning!
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
SNGX stock is elevating higher after Soligenix released positive results from its HyBryte study. Here are the company's top investors.
Here you can normally see the latest stock twits on SNGX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: